NFKB1 and neoplasm: In addition, high expression of nuclear factor kappa-B (NF-κb) was found in the tumor tissues with inferior DRAIC, and vitro and vivo studies verified that DRAIC could inhibit activation of NF-κb and prostate cancer progressions via binding to subunits of the IκB kinase (IKK) complex [12].